FDA
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) PT Raised to $215 at BTIG
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) PT Raised to $140 at BTIG
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
-
-
-
-
-
-
-
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - IRTC
-
-
-
-
-
-
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
-
322,240 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

